Jove
Visualize
Contact Us

Related Experiment Videos

Introduction to mannan-binding lectin.

D C Kilpatrick1

  • 1Scottish National Blood Transfusion Service National Science Laboratory, Ellen's Glen Road, Edinburgh EH17 7QT, UK. dave.kilpatrick@snbts.csa.scot.nhs.uk

Biochemical Society Transactions
|July 31, 2003
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Can ficolin-2 (L-ficolin) insufficiency be established by a single serum protein measurement?

International journal of immunogenetics·2015
Same author

Drug modification of LPS-stimulated human monocyte-derived dendritic cells.

British journal of biomedical science·2012
Same author

Mechanisms and assessment of mitogenesis : an overview.

Methods in molecular medicine·2011
Same author

Use of lectins as mitogens for lymphocytes.

Methods in molecular medicine·2011
Same author

MBL really binds to healthy human cells!

Scandinavian journal of immunology·2007
Same author

Extremes of L-ficolin concentration in children with recurrent infections are associated with single nucleotide polymorphisms in the FCN2 gene.

Clinical and experimental immunology·2007
Same journal

TDP-43 proteinopathy as a biomarker and therapeutic target in amyotrophic lateral sclerosis.

Biochemical Society transactions·2026
Same journal

Advancing the monitoring of organelle contact sites in vitro and in vivo.

Biochemical Society transactions·2026
Same journal

Mechanisms influencing transient cytoplasmic protein targeting to intracellular lipid droplets.

Biochemical Society transactions·2026
Same journal

Replication associated nuclear DNA mismatch repair across kingdoms.

Biochemical Society transactions·2026
Same journal

Phosphatases of regenerating liver downregulate PTEN to promote tumorigenesis.

Biochemical Society transactions·2026
Same journal

Implications of Rho GTPase signaling in cancer immunotherapy.

Biochemical Society transactions·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Mannan-binding lectin (MBL), a key innate immunity component, shows promise in replacement therapy for various diseases. Further trials with recombinant MBL are needed to confirm its physiological significance and therapeutic potential.

Area of Science:

  • Immunology
  • Biochemistry

Background:

  • Mannan-binding lectin (MBL) is a collectin and C-type lectin synthesized by the liver.
  • It functions as an opsonin and plays a role in innate immunity, acting as an anti-antibody or disease modifier.

Purpose of the Study:

  • To explore the role of MBL in innate immunity.
  • To investigate the potential of MBL replacement therapy for various disorders.

Main Methods:

  • Biochemical characterization of MBL.
  • Review of existing MBL replacement therapy data.

Main Results:

  • MBL influences diverse conditions including meningococcal disease, rheumatoid arthritis, cystic fibrosis, and recurrent miscarriage.
  • MBL deficiency is most critical when secondary immune deficiencies are present.

Related Experiment Videos

  • Early MBL replacement therapy using plasma showed promising results.

    • Conclusions:

    • MBL is a significant glycoprotein in innate immunity.
    • MBL replacement therapy holds therapeutic promise.
    • Development of recombinant MBL is crucial for large-scale clinical trials to establish its physiological significance.